Nadler Financial Group Inc. Decreases Stock Holdings in JPMorgan Chase & Co. $JPM

Nadler Financial Group Inc. decreased its holdings in JPMorgan Chase & Co. (NYSE:JPM) by 1.1% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,796 shares of the financial services provider’s stock after selling 64 shares during the quarter. Nadler Financial Group Inc.’s holdings in JPMorgan Chase & Co. were worth $1,680,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of JPM. Brighton Jones LLC raised its position in JPMorgan Chase & Co. by 11.0% in the 4th quarter. Brighton Jones LLC now owns 48,732 shares of the financial services provider’s stock worth $11,682,000 after buying an additional 4,841 shares during the last quarter. GAMMA Investing LLC raised its position in JPMorgan Chase & Co. by 5.8% in the 1st quarter. GAMMA Investing LLC now owns 96,029 shares of the financial services provider’s stock worth $23,556,000 after buying an additional 5,296 shares during the last quarter. Ironwood Wealth Management LLC. raised its position in JPMorgan Chase & Co. by 0.7% in the 1st quarter. Ironwood Wealth Management LLC. now owns 15,400 shares of the financial services provider’s stock worth $3,778,000 after buying an additional 107 shares during the last quarter. Acorns Advisers LLC raised its position in JPMorgan Chase & Co. by 6.9% in the 1st quarter. Acorns Advisers LLC now owns 1,547 shares of the financial services provider’s stock worth $379,000 after buying an additional 100 shares during the last quarter. Finally, Center for Financial Planning Inc. raised its position in JPMorgan Chase & Co. by 2.2% in the 1st quarter. Center for Financial Planning Inc. now owns 17,254 shares of the financial services provider’s stock worth $4,233,000 after buying an additional 379 shares during the last quarter. Hedge funds and other institutional investors own 71.55% of the company’s stock.

Insiders Place Their Bets

In other JPMorgan Chase & Co. news, Director Linda Bammann sold 9,500 shares of the company’s stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $297.94, for a total value of $2,830,430.00. Following the completion of the transaction, the director directly owned 82,207 shares in the company, valued at $24,492,753.58. This represents a 10.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.47% of the stock is owned by insiders.

JPMorgan Chase & Co. Trading Up 0.1%

JPM stock opened at $294.37 on Friday. JPMorgan Chase & Co. has a 1-year low of $202.16 and a 1-year high of $318.01. The company has a debt-to-equity ratio of 1.26, a current ratio of 0.86 and a quick ratio of 0.88. The company has a market capitalization of $809.44 billion, a price-to-earnings ratio of 14.58, a PEG ratio of 1.77 and a beta of 1.13. The business has a 50 day simple moving average of $303.23 and a two-hundred day simple moving average of $280.54.

JPMorgan Chase & Co. (NYSE:JPM) last posted its quarterly earnings results on Tuesday, October 14th. The financial services provider reported $5.07 earnings per share for the quarter, topping the consensus estimate of $4.83 by $0.24. JPMorgan Chase & Co. had a return on equity of 17.18% and a net margin of 20.90%.The business had revenue of $46.43 billion during the quarter, compared to the consensus estimate of $44.42 billion. During the same period in the prior year, the company posted $4.37 EPS. The firm’s revenue for the quarter was up 8.8% compared to the same quarter last year. Research analysts anticipate that JPMorgan Chase & Co. will post 18.1 EPS for the current fiscal year.

JPMorgan Chase & Co. Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Monday, October 6th will be paid a $1.50 dividend. This represents a $6.00 annualized dividend and a yield of 2.0%. The ex-dividend date is Monday, October 6th. This is a positive change from JPMorgan Chase & Co.’s previous quarterly dividend of $1.40. JPMorgan Chase & Co.’s dividend payout ratio is currently 29.72%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on JPM shares. Truist Financial upped their price target on shares of JPMorgan Chase & Co. from $290.00 to $319.00 and gave the company a “hold” rating in a research report on Tuesday, September 23rd. Wells Fargo & Company upped their price target on shares of JPMorgan Chase & Co. from $325.00 to $345.00 and gave the company an “overweight” rating in a research report on Tuesday, September 16th. Robert W. Baird lowered shares of JPMorgan Chase & Co. from a “neutral” rating to an “underperform” rating and set a $235.00 price target for the company. in a research report on Friday, June 27th. Wolfe Research upped their price target on shares of JPMorgan Chase & Co. from $342.00 to $346.00 and gave the company an “outperform” rating in a research report on Thursday, October 16th. Finally, HSBC reaffirmed a “reduce” rating and set a $259.00 price target on shares of JPMorgan Chase & Co. in a research report on Tuesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $322.27.

JPMorgan Chase & Co. Company Profile

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate.